AbbVie stock hit a new 52-week high, rising nearly 130% over five years, raising valuation questions.
Finnhub06/29, 10:41 PM
Related assets
Coming up for ABBV
Explore next
Latest ABBV news
FirstSquawk08/20, 09:57 AM
Piper Sandler raised its price target on AbbVie to $303 from $298.
Bloomberg08/17, 06:28 PM
Bloomberg08/03, 04:58 PM